At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CR crane
Closed Good Friday 04-17 16:00:00 EDT
142.65
+1.08
+0.76%
盘后142.60
+0.000.00%
17:13 EDT
| High143.85 | Low140.97 | Vol264.63K |
| Open142.10 | D1 Closing141.57 | Amplitude2.03% |
| Mkt Cap8.20B | Tradable Cap6.93B | Total Shares57.48M |
| T/O37.70M | T/O Rate0.54% | Tradable Shares48.60M |
| P/B5.00 | ROE17.87% | EPS5.05 |
| 52wk High188.52 | 52wk Low127.04 | P/E28.22 |
| Dividend0.82 | Div.Yield0.01 | ROA8.53% |
Crane Company (CR) Receives a Rating Update from a Top Analyst
TIPRANKS · 04-14
Crane, Kennametal, International Paper, Lennar, and KB Home Shares Plummet, What You Need To Know
StockStory · 04-10
CERo Therapeutics Holdings, Inc. Announces Initial Clinical Trial Site for its Phase 1 Clinical Trial of CER-1236 in Acute Myeloid Leukemia
GlobeNewswire · 04-09
Crane (CR): Buy, Sell, or Hold Post Q4 Earnings?
StockStory · 04-02
Press Release: Crane Company Announces Date for First Quarter 2025 Earnings Release and Teleconference
Dow Jones · 04-01
Crane Company Announces Date for First Quarter 2025 Earnings Release and Teleconference
THOMSON REUTERS · 04-01
Tovecimig (CTX-009) Meets Primary Endpoint in the Ongoing Randomized Phase 2/3 Study in Patients with Biliary Tract Cancer
GlobeNewswire · 04-01
Ingersoll Rand Stock Boasts Strong Prospects Despite Headwinds
Zacks · 03-31
Curis Provides Fourth Quarter 2024 Business Update
PR Newswire · 03-31
Press Release: CG Oncology Reports 2024 Year End Financial Results and Provides Business Updates
Dow Jones · 03-28
Sensei Biotherapeutics Reports Favorable Preliminary Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors
GlobeNewswire · 03-27
Press Release: Tyra Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights
Dow Jones · 03-27
Actinium Pharmaceuticals Announces ATNM-400 a Novel Non-PSMA Targeting First in Class Prostate Cancer Radiotherapy Leveraging Actinium-225
PR Newswire · 03-27
CERo Therapeutics Holdings, Inc. Poised to Initiate Enrollment of Phase 1 Trial of CER-1236 in AML Following Positive FDA Review of Manufacturing
GlobeNewswire · 03-27
Equillium Announces Results of the Phase 3 EQUATOR Study of Itolizumab in First-Line Treatment of Patients with Acute Graft-Versus-Host Disease
Business Wire · 03-27
Equillium Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate and Clinical Highlights
Business Wire · 03-27
Junshi Biosciences Announces Toripalimab’s Approval in Singapore
GlobeNewswire · 03-27
Actinium Pharmaceuticals to Present Business Update at Trump Mar-A-Lago Club Today
PR Newswire · 03-26
Is Crane Company (NYSE:CR) One of the Best Stocks to Buy According to Billionaire Mario Gabelli?
Insider Monkey · 03-25
Actinium Pharmaceuticals to Host KOL Investor Call at 8am ET Today to Highlight Revamped Clinical Programs and Expanded Market Opportunities Including Newly Initiated Actimab-A Solid Tumor Program
PR Newswire · 03-25
Introduction
Company Name.
crane
Affiliated Markets:
ARCA
Listing Date:
--
Main Business:
Crane NXT, Co. focuses on payment and merchandising technologies. It indents to offer electronic equipment and associated software leveraging extensive, and proprietary core capabilities, including payment verification and authentication, as well as automation solutions, field service solutions, remote diagnostics, and productivity enhancing software solutions. The company is based in Stamford, Connecticut.
Issue price:
--
Invest in Global Markets with Tiger Brokers!Open App